02690nam 22006015 450 991098048270332120250217115404.09783031740466303174046710.1007/978-3-031-74046-6(CKB)37627993300041(MiAaPQ)EBC31912093(Au-PeEL)EBL31912093(DE-He213)978-3-031-74046-6(OCoLC)1503842835(EXLCZ)993762799330004120250217d2024 u| 0engur|||||||||||txtrdacontentcrdamediacrrdacarrierAntiarrhythmic Drugs /edited by Antoni Martínez-Rubio, Juan Tamargo, G.-Andrei Dan2nd ed. 2024.Cham :Springer Nature Switzerland :Imprint: Springer,2024.1 online resource (732 pages)9783031740459 3031740459 Introduction: Cardiac arrhythmias a clinical problem -- Electrophysiological basis of the arrhythmias -- Class I antiarrhythmic drugs (Na+ channel blockers) -- Potassium-channel blockers -- Betablockers -- Modulation of calcium handling/Calcium-channel modulators -- Other antiarrhythmic drugs: Novel targets for AADs -- Non-antiarrhythmic drugs with antiarrhythmic effects -- Clinical management of the arrhythmias.This extensively updated edition reviews current and potential future therapies for cardiac arrhythmias. Developing the highly practical format of the original, this edition provides a thorough guide for the use of pharmaceuticals in the management of the condition and is focused on providing a clinical manual for arrhythmia treatment. Antiarrhythmic Drugs builds on the current understanding of pathophysiological mechanisms and insights gained from previous studies of therapeutic interventions. It is designed to establish the baseline level of knowledge that a cardiovascular professional needs to know on a day-to-day basis.CardiologyPharmacologyTherapeuticsCardiologyPharmacologyTherapeuticsCardiology.Pharmacology.Therapeutics.Cardiology.Pharmacology.Therapeutics.616.12Martínez-Rubio Antoni1788469Tamargo Juan1788470Dan G. -Andrei1788471MiAaPQMiAaPQMiAaPQBOOK9910980482703321Antiarrhythmic Drugs4323404UNINA02940nam 2200661Ia 450 991095568970332120240417004744.09786612412639978030914546603091454659781282412637128241263997803091301030309130107(CKB)2430000000010795(EBL)3378543(SSID)ssj0000443766(PQKBManifestationID)12122937(PQKBTitleCode)TC0000443766(PQKBWorkID)10461709(PQKB)10647753(MiAaPQ)EBC3378543(Au-PeEL)EBL3378543(CaPaEBR)ebr10347047(CaONFJC)MIL241263(OCoLC)923280960(Perlego)4737488(EXLCZ)99243000000001079520091002d2009 uy 0engur|n|---|||||txtccrUnderstanding research, science, and technology parks global best practices, report of a symposium /Committee on Comparative Innovation Policy: Best Practice for the 21st Century, Board on Science, Technology, and Economic Policy, Policy and Global Affairs, National Research Council; Charles W. Wessner, editor1st ed.Washington, D.C. National Academies Pressc20091 online resource (214 p.)Description based upon print version of record.9780309137898 0309137896 Includes bibliographical references.""Contents""; ""Preface""; ""Summary""; ""I INTRODUCTION""; ""Introduction: Research Parks in the 21st Century""; ""II PROCEEDINGS""; ""Welcome--Charles Wessner""; ""Keynote Address I--Jeff Bingaman""; ""Keynote Address II--C. D. Mote, Jr.""; ""Panel I: Leading Asian Models of S&T Parks""; ""Panel II: North American and European S&T Parks""; ""Keynote Address III--James Barker""; ""Panel III: U.S. Parks: The Laboratory Model""; ""Panel IV: U.S. Parks: University-Based Models""; ""Panel V: The Evaluation Challenge and Policy Synergies""; ""Closing Remarks--Mary Good""; ""III RESEARCH PAPER""""Research, Science, and Technology Parks: An Overview of the Academic Literature--Albert N. Link""""IV: APPENDIXES""; ""Appendix A: Biographies of Speakers""; ""Appendix B: Participants List""; ""Appendix C: Bibliography""Research parksInformation technology parksResearch parks.Information technology parks.507.2Wessner Charles W857991National Academies Press (U.S.)MiAaPQMiAaPQMiAaPQBOOK9910955689703321Understanding research, science, and technology parks4357548UNINA